erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Rhinitis D012220 10 associated lipids
Skin Ulcer D012883 6 associated lipids
Heart Diseases D006331 8 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Multiple Myeloma D009101 13 associated lipids
Quadriplegia D011782 4 associated lipids
Pain, Postoperative D010149 13 associated lipids
Porphyrias D011164 2 associated lipids
Femoral Fractures D005264 7 associated lipids
Hematuria D006417 13 associated lipids
Labyrinth Diseases D007759 3 associated lipids
Weight Gain D015430 101 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Abnormalities, Drug-Induced D000014 10 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Endocarditis, Bacterial D004697 5 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Obesity D009765 29 associated lipids
Bradycardia D001919 13 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Intraoperative Complications D007431 5 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Eye Diseases D005128 12 associated lipids
Salpingitis D012488 2 associated lipids
Leukemia D007938 74 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Fractures, Open D005597 3 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Crohn Disease D003424 12 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Cholestasis D002779 23 associated lipids
Sinusitis D012852 9 associated lipids
Glomerulonephritis D005921 35 associated lipids
Sepsis D018805 11 associated lipids
Nervous System Diseases D009422 37 associated lipids
Enterocolitis, Pseudomembranous D004761 8 associated lipids
Ataxia D001259 20 associated lipids
Psoriasis D011565 47 associated lipids
Urinary Tract Infections D014552 11 associated lipids
Cross Infection D003428 9 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Wound Infection D014946 12 associated lipids
Bacteriuria D001437 7 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Malke H Transfer of a plasmid mediating antibiotic resistance between strains of Streptococcus pyogenes in mixed cultures. 1975 Z. Allg. Mikrobiol. pmid:769365
Malke H Interaction of chromosomal mutations to erythromycin resistance with plasmid-mediated resistance to erythromycin and lincomycin in Streptococcus pyogenes. 1977 Z. Allg. Mikrobiol. pmid:337688
Osman HG et al. Utilization of Egyptian raw by-products for the erythromycin production by Streptomyces erythreus. 1968 Z. Allg. Mikrobiol. pmid:4989340
Malke H Transductional analysis of resistance to lincomycin and erythromycin in Streptococcus pyogenes. 1972 Z. Allg. Mikrobiol. pmid:4568554
Riemelt I et al. [Conjugational plasmid transfer from A, B and H streptococci to N streptococci]. 1984 Z. Allg. Mikrobiol. pmid:6441362
Dworsky P [Effect of inhibitors of protein and nucleic acid synthesis on the shape of the nucleoid of Escherichia coli]. 1974 Z. Allg. Mikrobiol. pmid:4142904
Schuhmann E and Taubeneck U [L forms of Escherichia coli K 12 (lambda). I. Induction and mode of multiplication]. 1971 Z. Allg. Mikrobiol. pmid:4107077
Koopman JP et al. Influence of the antibiotics roxithromycin and erythromycin on the gastro-intestinal ecology of mice. 1987 Z Versuchstierkd pmid:3324551
Baumüller A et al. [Bacterial prostatitis--therapeutic principles]. 1977 Z Urol Nephrol pmid:919805
Busch H and Unger K [Studies on pathogen spectra and resistance quotas of infection producing organisms in surgical and urologic diseases in common hospitalization and separate ambulatory settings]. 1975 Z Urol Nephrol pmid:775851
BESZNYAK I et al. [THE ANTIBIOGRAM OF THORACIC EMPYEMA AND ITS LOCAL ANTIBIOTIC THERAPY]. 1964 Z Tuberk Erkr Thoraxorg pmid:14141375
BALDAMUS U [Antibiotic treatment of unspecific plombage empyema]. 1956 Z Tuberk pmid:13353453
Quincke G [Sensitivity to penicillin of gonococcal strains isolated in Lomé, Togo]. 1970 Z Tropenmed Parasitol pmid:4992455
Pulverer G [Studies with lysotaphin. II. Lysostaphin sensitivity of 230 strains of Staph. aureus of animal origin]. 1968 Z Med Mikrobiol Immunol pmid:5751715
Kayser FH [Effect of benzylpenicillin and ampicillin on enterococci]. 1971 Z Med Mikrobiol Immunol pmid:5554809
Pulverer G [Studies with lysostaphin. I. Lysostaphin sensitivity of 355 strains of Staph. aureus of human origin]. 1968 Z Med Mikrobiol Immunol pmid:5710870
Goldmann SF and Heiss F [The phenomenom of resistance and cross resistance to erythromycin, lincomycin and staphylomycin]. 1971 Z Med Mikrobiol Immunol pmid:4929058
Zierfels G and Petz M [Fluorimetric determination of erythromycin residues in foods of animal origin after derivatization with FMOC and HPLC separation]. 1994 Z Lebensm Unters Forsch pmid:8197827
Bláhová O and Drastík J [Antibiotics for recurrent acute otitis media in infants under two (author's transl)]. 1973 Z Laryngol Rhinol Otol pmid:4149361
Windorfer A and Mihailova K [Influence of various drugs and pH-values on albumin-bilirubin binding in vitro]. 1973 Z Kinderheilkd pmid:4686270
Mochmann H et al. [The sensitivity of B. pertussis to antibiotics. Examination of 122 patients' strains of B. pertussis]. 1969 Z Kinderheilkd pmid:4315563
Krauer-Mayer B [Antibacterial therapy in the newborn infant]. 1967 Z Kinderheilkd pmid:4297705
ZINZIUS J [Some side-effects of erythromycin]. 1955 Z Haut Geschlechtskr pmid:13257371
Landes E and Metz B [Syphilis therapy in penicillin incompatibility]. 1970 Z Haut Geschlechtskr pmid:5505299
DORN H [Lymphogranuloma venereum (primary lesion, late stage, treatment with erycinum)]. 1956 Z Haut Geschlechtskr pmid:13353318
WEISE HJ [Experiences with erythromycin in some skin diseases]. 1956 Z Haut Geschlechtskr pmid:13353333
Hudemann H [Staphylococci and mycoses as a cause of diarrhea]. 1974 Z Gesamte Inn Med pmid:4617437
Hirschelmann R and Bekemeier H [Anti-inflammatory effects of chemotherapeutics and antibiotics]. 1973 Z Gesamte Inn Med pmid:4779148
Tauchnitz C [Current status of antibiotic therapy]. 1973 Z Gesamte Inn Med pmid:4349582
Gebhart A and Cervený R [Contribution to the problem of staphylococcal enterocolitis]. 1966 Z Gesamte Inn Med pmid:5986532
Peeters TL [The potentials of erythromycin derivatives in the treatment of gastrointestinal motility disorders]. 1991 Z Gesamte Inn Med pmid:1926941
FRICKE G [Results with erycinum in internal diseases]. 1957 Z Gesamte Inn Med pmid:13468608
Tauchnitz C [Expedient therapy of chronic pyelonephritis]. 1970 Z Gesamte Inn Med pmid:4331735
Dittmer A [Use of antibiotics--principles and possibilities]. 1984 Z Gesamte Hyg pmid:6324502
Winkler M et al. [Puerperium after threatened premature labor--effects of infection screening in pregnancy]. 1994 Mar-Apr Z Geburtshilfe Perinatol pmid:8023535
Hoppe JE [Whooping cough in pregnant patients and newborn infants]. 1996 Nov-Dec Z Geburtshilfe Neonatol pmid:9081753
VON KOBYLETZKI D and STRAUCH [EXPERIMENTAL STUDIES ON THE PROBLEM OF DIAPLACENTAL PASSAGE AND THE EXCRETION OF ERYTHROMYCIN-ESTOLATE (PELS) WITH HUMAN MILK]. 1964 Z Geburtshilfe Gynakol pmid:14198621
Folwaczny C et al. [Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma]. 1997 Z Gastroenterol pmid:9432812
Wienbeck M and Barnert J [Principles of pharmacotherapy]. 1990 Z Gastroenterol pmid:2162581
Bassotti G et al. Effect of different doses of erythromycin on colonic motility in patients with slow transit constipation. 1998 Z Gastroenterol pmid:9577904
Schusdziarra V [Motilin and motilides--future perspectives for therapy of gastrointestinal motility disorders]. 1992 Z Gastroenterol pmid:1413940
Griga T et al. [Effect of stomach motility on measuring stomach permeability with saccharose in vivo]. 1999 Z Gastroenterol pmid:10378362
Neubrand M and Sauerbruch T Erythromycin, a motilin agonist, increases postprandial gallbladder emptying during therapy with ursodeoxycholic acid. 1998 Z Gastroenterol pmid:9612923
Naumann G [The detection of the agent of Legionnaires' disease--a confirmation of Koch's postulates]. 1983 Z Erkr Atmungsorgane pmid:6356647
Fischer P and Schilling W [Therapeutic results in lung diseases caused by atypical mycobacteria]. 1984 Z Erkr Atmungsorgane pmid:6202070
Kirsten D and Meister W [Present possibilities of antibiotic therapy in chronic non-specific respiratory diseases (author's transl)]. 1976 Z Erkr Atmungsorgane pmid:1049185
Ocklitz HW et al. [Pediatric guidelines. 3. Antibiotics--indications]. 1968 Z Arztl Fortbild (Jena) pmid:4978334
Dietzsch HJ et al. [Abscessed (staphylococcal) pneumonia in childhood]. 1972 Z Arztl Fortbild (Jena) pmid:4118084
Handrick W et al. [Contribution to the diagnosis and therapy of juvenile pneumonia]. 1981 Z Arztl Fortbild (Jena) pmid:7340181
Heite HJ [Therapy of venereal infections]. 1971 Z Allgemeinmed pmid:5108596
Uh Y et al. Correlation of serotypes and genotypes of macrolide-resistant Streptococcus agalactiae. 2005 Yonsei Med. J. pmid:16127771
Hatipoglu ON and Tasan Y A comparative efficacy and safety study of clarithromycin, roxithromycin and erythromycin stearate in mild pneumonia. 2000 Yonsei Med. J. pmid:10957888
Uh Y et al. Macrolide resistance trends in beta-hemolytic streptococci in a tertiary Korean hospital. 2007 Yonsei Med. J. pmid:17963333
Kim HY and Uh Y Macrolide resistance in beta-hemolytic streptococci: changes after the implementation of the separation of prescribing and dispensing of medications policy in Korea. 2004 Yonsei Med. J. pmid:15344198
Marmiroli N and Bilinski CA Partial restoration of meiosis in an apomictic strain of Saccharomyces cerevisiae: a model system for investigation of nucleomitochondrial interactions during sporulation. 1985 Yeast pmid:3916858
Goffrini P et al. RAG1 and RAG2: nuclear genes involved in the dependence/independence on mitochondrial respiratory function for growth on sugars. 1989 Mar-Apr Yeast pmid:2711752
Xu J et al. [Prognosticating the region-selectivity in the O-methylation reaction of erythromycins by conformational search model]. 2003 Yao Xue Xue Bao pmid:12778744
Liu L et al. [Synthesis of derivatives of (9S)-12-methylene erythromycin and their antibacterial activity in vitro]. 2005 Yao Xue Xue Bao pmid:16220785
Xu P et al. [Synthesis of derivatives of (9S) -9-hydroxyl-12-methylene erythromycin A and their antibacterial activity in vitro]. 2007 Yao Xue Xue Bao pmid:17703771
Sun W et al. [Glycosyl isomerization based on the biosynthesis of natural-product sugar from microorganism]. 2013 Yao Xue Xue Bao pmid:23672013
Chen HX et al. [Compound erythromycin sustained release preparation and its in vitro release]. 2011 Yao Xue Xue Bao pmid:22260035
Chen SX et al. [Synthesis and antibacterial activity of 3-hydroxy-6-O-methylerythromycin-9-O-substituted oxime derivatives]. 2001 Yao Xue Xue Bao pmid:12579933
Watanabe Y et al. [Relationship between quality and serum level after the oral administration of commercial erythromycin tablets in man (author's transl)]. 1977 Yakugaku Zasshi pmid:911413
Matsuoka M [Study of macrolide, lincosamide, and streptogramin B antibiotics resistance in Staphylococcus aureus]. 2000 Yakugaku Zasshi pmid:10774259
Nakamura H et al. Effect of particle size on mixing degree in dispensation. 2004 Yakugaku Zasshi pmid:15049131
Nakamura H et al. Effect of mixing method on the mixing degree during the preparation of triturations. 2004 Yakugaku Zasshi pmid:15049130
Watanabe Y et al. [Effect of dissolving pH of enteric coating agent on bioavailability of enteric coated tablets of erythromycin in man (author's transl)]. 1978 Yakugaku Zasshi pmid:30834
Miyazaki M et al. [Trends and antimicrobial susceptibilities of clinical methicillin-resistant Staphylococcus aureus isolates in Fukuoka University Chikushi Hospital 2008-2012]. 2014 Yakugaku Zasshi pmid:24492229
Otsuka M et al. [Studies on fungicides. XIV. Effect of erythromycin on the growth of fungal mycelia (author's transl)]. 1978 Yakugaku Zasshi pmid:566318
Zhang Y et al. [Erythromycin restores oxidative stress-induced corticosteroid responsiveness of human THP-1 cells by up-regulating the expression of histone deacetylase 2]. 2014 Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi pmid:24721407
Ung D et al. Metabolic interactions between prokinetic agents domperidone and erythromycin: an in vitro analysis. 2009 Xenobiotica pmid:19575604
Hu J et al. Possible multiple transporters were involved in hepatobiliary excretion of antofloxacin in rats. 2007 Xenobiotica pmid:17614005
Salimi A et al. Toxicity of macrolide antibiotics on isolated heart mitochondria: a justification for their cardiotoxic adverse effect. 2016 Xenobiotica pmid:26068526
Emoto C et al. Cooperativity of alpha-naphthoflavone in cytochrome P450 3A-dependent drug oxidation activities in hepatic and intestinal microsomes from mouse and human. 2001 Xenobiotica pmid:11491388
Bickel MH et al. Entero-bacterial formation of cyclohexylamine in rats ingesting cyclamate. 1974 Xenobiotica pmid:4372812
Yamazaki H et al. Effects of roxithromycin, erythromycin and troleandomycin on their N-demethylation by rat and human cytochrome P450 enzymes. 1996 Xenobiotica pmid:8948090
Pasic J et al. The interaction between chronic oral slow-release theophylline and single-dose intravenous erythromycin. 1987 Xenobiotica pmid:3604256
Yamazaki H and Shimada T Formation in vitro of an inhibitory cytochrome P450 x Fe2+-metabolite complex with roxithromycin and its decladinosyl, O-dealkyl and N-demethyl metabolites in rat liver microsomes. 1998 Xenobiotica pmid:9849646
Saitoh R et al. Nonlinear intestinal pharmacokinetics of mitemcinal, the first acid-resistant non-peptide motilin receptor agonist, in rats. 2007 Xenobiotica pmid:17926229
Berg-Candolfi M et al. Suppression of intestinal and hepatic cytochrome P4503A in murine Toxoplasma infection. Effects of N-acetylcysteine and N(G)-monomethyl-L-arginine on the hepatic suppression. 1996 Xenobiotica pmid:9173679
Villa P et al. Erythromycin toxicity in primary cultures of rat hepatocytes. 1985 Aug-Sep Xenobiotica pmid:4072263
Ward KW et al. Exploration of the African green monkey as a preclinical pharmacokinetic model: oral pharmacokinetic parameters and drug-drug interactions. 2009 Xenobiotica pmid:19280525
Ward KW et al. Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human. 2005 Xenobiotica pmid:16019946
Molnari JC and Myers AL Carbonyl reduction of bupropion in human liver. 2012 Xenobiotica pmid:22339467
Kaye B and Roberts DW The metabolism of oxamniquine in the gut wall. 1980 Xenobiotica pmid:7395269
Watanabe M et al. Role of CYP3A in bromperidol metabolism in rat in vitro and in vivo. 1999 Xenobiotica pmid:10553724
Kubo JI et al. Pharmacokinetic evaluation of high pulmonary disposition of clarithromycin after systemic administration. 2002 Xenobiotica pmid:12419017
Trepanier LA and Miller JL NADH-dependent reduction of sulphamethoxazole hydroxylamine in dog and human liver microsomes. 2000 Xenobiotica pmid:11307968
Guillouzo A et al. Human hepatocyte cultures: a model of pharmaco-toxicological studies. 1985 Aug-Sep Xenobiotica pmid:3907158
Kanazu T et al. Model for the drug-drug interaction responsible for CYP3A enzyme inhibition. I: evaluation of cynomolgus monkeys as surrogates for humans. 2004 Xenobiotica pmid:15370956
Attaran B et al. Effect of biofilm formation by clinical isolates of on the efflux-mediated resistance to commonly used antibiotics. 2017 World J. Gastroenterol. pmid:28275296
Niv E et al. Effect of erythromycin on image quality and transit time of capsule endoscopy: a two-center study. 2008 World J. Gastroenterol. pmid:18442206
Sári R et al. Ethanol inhibits the motility of rabbit sphincter of Oddi in vitro. 2004 World J. Gastroenterol. pmid:15526367
Liu ZQ et al. Efflux pump gene hefA of Helicobacter pylori plays an important role in multidrug resistance. 2008 World J. Gastroenterol. pmid:18777600
Leung WK et al. Effect of oral erythromycin on gastric and small bowel transit time of capsule endoscopy. 2005 World J. Gastroenterol. pmid:16097060
Lim CH et al. Effect of DA-9701 on gastric emptying in a mouse model: assessment by ¹³C-octanoic acid breath test. 2013 World J. Gastroenterol. pmid:23885150
Jiang DP et al. Treatment of pediatric Ogilvie's syndrome with low-dose erythromycin: a case report. 2007 World J. Gastroenterol. pmid:17461506
Suchitra AD et al. Relative efficacy of some prokinetic drugs in morphine-induced gastrointestinal transit delay in mice. 2003 World J. Gastroenterol. pmid:12679931
Condon RE Intestinal antisepsis: rationale and results. 1982 World J Surg pmid:7090403
Stone HH and Fabian TC Clinical comparison of antibiotic combinations in the treatment of peritonitis and related mixed aerobic-anaerobic surgical sepsis. 1980 World J Surg pmid:7233913